# Innovent Biologics, Inc. (IVBXF)

> Healthcare · CN · Reports in CNY

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IVBXF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | ¥ 12.92B | ¥ 813.91M | ¥ 9.64B | ¥ 2.82B | ¥ 19.37B |
| 2024 | ¥ 9.47B | ¥ -95.09M | ¥ 322.92M | ¥ 2.83B | ¥ 13.12B |
| 2023 | ¥ 6.24B | ¥ -1.03B | ¥ -977.24M | ¥ 3.62B | ¥ 12.53B |
| 2022 | ¥ 4.57B | ¥ -2.19B | ¥ -2.82B | ¥ 3.23B | ¥ 10.73B |
| 2021 | ¥ 4.36B | ¥ -2.79B | ¥ -3.15B | ¥ 2.50B | ¥ 10.33B |
| 2020 | ¥ 3.98B | ¥ -1.03B | ¥ -824.93M | ¥ 1.21B | ¥ 8.78B |
| 2019 | ¥ 1.09B | ¥ -1.79B | ¥ -2.11B | ¥ 865.09M | ¥ 4.76B |
| 2018 | ¥ 10.27M | ¥ -6.26B | ¥ -1.44B | ¥ 792.00M | ¥ 4.19B |
| 2017 | ¥ 82.82M | ¥ -621.24M | ¥ -644.35M | ¥ 510.00M | ¥ -1.94B |
| 2016 | ¥ 36.15M | ¥ -567.35M | ¥ -474.22M | ¥ 500.00M | ¥ -1.38B |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.15 |
| Liabilities / Eq | 0.89 |
| Current Ratio | 2.62 |

## Other views

- [Metrics](https://sponda.capital/en/IVBXF.md)
- [Charts](https://sponda.capital/en/IVBXF/charts.md)
- [Compare](https://sponda.capital/en/IVBXF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.